These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35441357)

  • 1. Establishment and characterization of a novel patient-derived Ewing sarcoma cell line, NCC-ES2-C1.
    Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Ono T; Akiyama T; Nakagawa R; Kamio S; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
    Hum Cell; 2022 Jul; 35(4):1262-1269. PubMed ID: 35441357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a novel patient-derived Ewing's sarcoma cell line, NCC-ES1-C1.
    Oyama R; Kito F; Qiao Z; Sakumoto M; Noguchi R; Takahashi M; Toki S; Tanzawa Y; Yoshida A; Kawai A; Kondo T
    In Vitro Cell Dev Biol Anim; 2018 Dec; 54(10):770-778. PubMed ID: 30324244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical heterogeneity of round cell sarcomas with EWSR1/FUS gene fusions: Impact of gene fusion type on clinical features and outcome.
    Tsuda Y; Zhang L; Meyers P; Tap WD; Healey JH; Antonescu CR
    Genes Chromosomes Cancer; 2020 Sep; 59(9):525-534. PubMed ID: 32362012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary subcutaneous spindle cell Ewing sarcoma with strong S100 expression and EWSR1-FLI1 fusion: a case report.
    Arnold MA; Ballester LY; Pack SD; Abdullaev Z; Merchant M; Tsokos MG
    Pediatr Dev Pathol; 2014; 17(4):302-7. PubMed ID: 24735198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and characterization of NCC-CDS2-C1: a novel patient-derived cell line of CIC-DUX4 sarcoma.
    Yoshimatsu Y; Noguchi R; Tsuchiya R; Kito F; Sei A; Sugaya J; Nakagawa M; Yoshida A; Iwata S; Kawai A; Kondo T
    Hum Cell; 2020 Apr; 33(2):427-436. PubMed ID: 31898195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct transcriptional signature and immunoprofile of CIC-DUX4 fusion-positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas: further evidence toward distinct pathologic entities.
    Specht K; Sung YS; Zhang L; Richter GH; Fletcher CD; Antonescu CR
    Genes Chromosomes Cancer; 2014 Jul; 53(7):622-33. PubMed ID: 24723486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of NCC-ASPS1-C1: a novel patient-derived cell line of alveolar soft-part sarcoma.
    Yoshimatsu Y; Noguchi R; Tsuchiya R; Sei A; Sugaya J; Fukushima S; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2020 Oct; 33(4):1302-1310. PubMed ID: 32648033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EWSR1-FLI1 Activation of the Cancer/Testis Antigen FATE1 Promotes Ewing Sarcoma Survival.
    Gallegos ZR; Taus P; Gibbs ZA; McGlynn K; Gomez NC; Davis I; Whitehurst AW
    Mol Cell Biol; 2019 Jul; 39(14):. PubMed ID: 31036566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An
    Bissonnette C; Shilo K; Liebner D; Rogers A; Pollock RE; Iwenofu OH
    Int J Surg Pathol; 2021 Feb; 29(1):109-116. PubMed ID: 32506986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and characterization of NCC-SS5-C1: a novel patient-derived cell line of synovial sarcoma.
    Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Ono T; Akiyama T; Sugaya J; Kojima N; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2022 Jul; 35(4):1290-1297. PubMed ID: 35655041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of NCC-SS6-C1: a novel patient-derived cell line of synovial sarcoma.
    Osaki J; Noguchi R; Ono T; Adachi Y; Iwata S; Toda Y; Funada T; Iwata S; Kojima N; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2024 Nov; 37(6):1734-1741. PubMed ID: 39174825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ewing sarcoma of the small bowel: a study of seven cases, including one with the uncommonly reported EWSR1-FEV translocation.
    Milione M; Gasparini P; Sozzi G; Mazzaferro V; Ferrari A; Casali PG; Perrone F; Tamborini E; Pellegrinelli A; Gherardi G; Arrigoni G; Collini P; Testi A; De Paoli E; Aiello A; Pilotti S; Pelosi G
    Histopathology; 2014 Jun; 64(7):1014-26. PubMed ID: 24898918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated multimodal genetic testing of Ewing sarcoma--a single-institution experience.
    Warren M; Weindel M; Ringrose J; Venable C; Reyes A; Terashima K; Rao P; Chintagumpala M; Hicks MJ; Lopez-Terrada D; Lu XY
    Hum Pathol; 2013 Oct; 44(10):2010-9. PubMed ID: 23706910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ewing sarcoma with FEV gene rearrangements is a rare subset with predilection for extraskeletal locations and aggressive behavior.
    Tsuda Y; Dickson BC; Swanson D; Sung YS; Zhang L; Meyers P; Healey JH; Antonescu CR
    Genes Chromosomes Cancer; 2020 May; 59(5):286-294. PubMed ID: 31756779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ewing sarcoma inhibition by disruption of EWSR1-FLI1 transcriptional activity and reactivation of p53.
    van der Ent W; Jochemsen AG; Teunisse AF; Krens SF; Szuhai K; Spaink HP; Hogendoorn PC; Snaar-Jagalska BE
    J Pathol; 2014 Aug; 233(4):415-24. PubMed ID: 24974828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment and characterization of NCC-SS3-C1: a novel patient-derived cell line of synovial sarcoma.
    Yoshimatsu Y; Noguchi R; Tsuchiya R; Sei A; Sugaya J; Iwata S; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2020 Jul; 33(3):877-885. PubMed ID: 32274656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and characterization of NCC-UPS4-C1: a novel cell line of undifferentiated pleomorphic sarcoma from a patient with Li-Fraumeni syndrome.
    Ono T; Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Akiyama T; Sugaya J; Fukushima S; Kojima N; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2022 Mar; 35(2):756-766. PubMed ID: 35118583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological and molecular spectrum of ewing sarcomas/PNETs, including validation of EWSR1 rearrangement by conventional and array FISH technique in certain cases.
    Rekhi B; Vogel U; Basak R; Desai SB; Jambhekar NA
    Pathol Oncol Res; 2014 Jul; 20(3):503-16. PubMed ID: 24293381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma.
    Loganathan SN; Tang N; Fleming JT; Ma Y; Guo Y; Borinstein SC; Chiang C; Wang J
    Oncotarget; 2016 Jul; 7(28):43504-43517. PubMed ID: 27259270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An inducible ectopic expression system of EWSR1-FLI1 as a tool for understanding Ewing sarcoma oncogenesis.
    García-Domínguez DJ; Hontecillas-Prieto L; León EA; Sánchez-Molina S; Rodríguez-Núñez P; Morón FJ; Hajji N; Mackintosh C; de Álava E
    PLoS One; 2020; 15(6):e0234243. PubMed ID: 32502203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.